Form 4 for SPRB SPRUCE BIOSCIENCES, INC.
Accepted 2022-01-05 00:00:00 ET · period of report 2021-12-31 · accession 0001209191-22-001621 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-05 | 2021-12-31 | SPRB | Gharib Samir M. | Pres, CFO | J - Other | $3.79 | +2,220 | 4,632 | +92% | +$8,414 |
| D | 2022-01-05 | 2022-01-03 | SPRB | Gharib Samir M. | Pres, CFO | A - Grant | $0.00 | +70.0K | 70.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-31 | J | A | 2,220 | $3.79 | 4,632 | D | — | — | (F1) Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-01-03 | A | A | 70,000 | $0.00 | 70,000 | D | $4.59 · — to 2032-01-02 | 70,000 Common Stock | (F2) 1/48th of the shares vest on a monthly basis from January 3, 2022, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). |